Atlas Trials

A Study of Endostar Combined With Chemotherapy and Immunotherapy in Lung Squamous Cell Carcinom

Clinical trial NCT05782764 · UNKNOWN

Trial details

NCT number
NCT05782764
Sponsor
Xuzhou Medical University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Lung Squamous Cell Carcinoma
Start date
2023-06-01
Primary completion
2025-05-30
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.